ミラバイオロジクス ロゴ

We bring “miracles in medicine” to make a better future (mirai) in people's lives.

ABOUT US

INNOVATIVE NEOBIOLOGICS

We use a simple, elegant technology called LassoGraft Technology® to extend the boundaries of biopharmaceuticals, creating new, innovative Neobiologics (multifunctional biopharmaceuticals) and bringing them to those who need them.

Portfolio

We build up a rich, varied portfolio by applying LassoGraft Technology® to a wide variety of modalities and therapeutic areas.

PORTFOLIO
元素 イメージ

Science

LassoGraft Technology®, by grafting target-specific cyclic peptides onto any proteins in the body, transforms them into biologically active proteins, creating new biopharmaceutical Neobiologics.

SCIENCE
  • Speed
  • Robustness and reliability
  • Plug & Play
  • Multifunctionality

Partnership

In drug development, we value collaboration with pharmaceutical companies. The essence of collaboration is to combine our partners’ drug development expertise and experience with our LassoGraft Technology®, to create cutting-edge biopharmaceuticals rapidly and deliver them to patients worldwide who need them.

PARTNERSHIP

News

ALL NEWS
  • 2024.02.16
    [Japanese only] Our founding director, Professor Hiroaki Suga at the University of Tokyo, is scheduled to speak at the Nikkei Business Innovation Forum to be held on March 15. Pre-registration is required, and there is no charge to attend. https://events.nikkei.co.jp/65515/
  • 2024.01.30
    We participated in a partnering event, Biotech Showcase 2024 (Monday, January 8 - Wednesday, January 10, 2024 in San Francisco), where our CEO, Masuhiro Kato, gave a presentation. Please click on the link below to subscribe to the webcast and watch the video of the presentation.
  • 2023.08.21
    We will have a booth at BioJapan, a partnering event (Location: Pacifico Yokohama, October 11 (Wed) - 13 (Fri), 2023, 10:00-17:00). We will be located at booth area, booth number: C-12, so please stop by if you are interested in our activities.
  • 2023.07.01
    We have opened an official LinkdIn account for MiraBiologics, Inc. We will announce hot information about our company from time to time, so please follow us if you are interested.
  • 2023.06.27
    June 26: Our founding director, Professor Hiroaki Suga at the University of Tokyo, attended the 2023 Wolf Prize for Chemistry award ceremony held on June 15 and accepted the award. We congratulate him on receiving the prestigious Wolf Prize.
  • 2023.05.10
    May 10: We have renewed our website.